Pharmanutra S.p.A. (BIT:PHN)
47.00
-0.30 (-0.63%)
Sep 5, 2025, 9:44 AM CET
Pharmanutra Revenue
Pharmanutra had revenue of 26.82M EUR in the quarter ending March 31, 2025, with 12.56% growth. This brings the company's revenue in the last twelve months to 118.93M, up 17.60% year-over-year. In the year 2024, Pharmanutra had annual revenue of 116.15M with 15.33% growth.
Revenue (ttm)
118.93M
Revenue Growth
+17.60%
P/S Ratio
3.82
Revenue / Employee
1.01M
Employees
118
Market Cap
454.23M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 116.15M | 15.44M | 15.33% |
Dec 31, 2023 | 100.71M | 17.64M | 21.24% |
Dec 31, 2022 | 83.06M | 14.92M | 21.89% |
Dec 31, 2021 | 68.14M | 11.38M | 20.04% |
Dec 31, 2020 | 56.77M | 3.10M | 5.78% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Recordati Industria Chimica e Farmaceutica | 2.48B |
DiaSorin | 1.22B |
Amplifon | 2.41B |
EL.En. | 577.19M |
Philogen | 77.65M |
Safilo Group | 998.89M |
GPI S.p.A. | 509.93M |
Garofalo Health Care | 470.20M |